Decoy Therapeutics is trading at $4.11, up 61.53% in pre-market, with no clear explanation identified.
- No fresh company-specific announcement or overnight filing was identified for September 22, 2026.
- The latest notable disclosure was September 15 shareholder approval of warrant issuance and reduced authorized shares; it predates the move and does not clearly explain the surge.
- Broader markets were only modestly higher, so macro sentiment does not adequately explain the move; the spike requires follow-up.